Cargando…

The Immunosuppressant Protosappanin A Diminished Recipient T Cell Migration into Allograft via Inhibition of IP-10 in Rat Heart Transplant

The immunosuppressant Protosappanin A (PrA), isolated from the medicinal herb, promotes cardiac allograft survival, diminishes inflammatory cell infiltration, and inhibits interferon γ-induced protein 10 kDa (IP-10) mRNA expression in rats cardiac grafts. Binding of the chemokine IP-10 to its cognat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Maomao, He, Jieqiong, Hou, Jingbo, Wu, Jian, Sun, Meng, Cui, Jinjin, Tian, Jiangtian, Jiang, Miaomiao, Yu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010525/ https://www.ncbi.nlm.nih.gov/pubmed/24798458 http://dx.doi.org/10.1371/journal.pone.0096138

Ejemplares similares

The Immunosuppressant Protosappanin A Promotes Dendritic Cell-Mediated Expansion of Alloantigen-Specific Tregs and Prolongs Allograft Survival in Rats
por: Zhang, Maomao, et al.
Publicado: (2013)

EXCELLENT ALLOGRAFT RECOVERY DESPITE PROLONGED SARS-COV-2 SHEDDING AFTER REDUCTION OF IMMUNOSUPPRESSION IN LUNG TRANSPLANT RECIPIENT
por: RAZIA, DEEPIKA, et al.
Publicado: (2021)

Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
por: Hancock, Wayne W., et al.
Publicado: (2001)

Protosappanin B promotes apoptosis and causes G(1) cell cycle arrest in human bladder cancer cells
por: Yang, Xihua, et al.
Publicado: (2019)

Protosappanin B Exerts Anti-tumor Effects on Colon Cancer Cells via Inhibiting GOLPH3 Expression
por: Zheng, Xue-Cong, et al.
Publicado: (2020)

Posterior reversible encephalopathy syndrome in a renal allograft recipient: A complication of immunosuppression?
por: Alexander, S., et al.
Publicado: (2013)

Causes of death in renal transplant recipients with functioning allograft
por: Prakash, J., et al.
Publicado: (2012)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Immune monitoring of allograft status in kidney transplant recipients
por: Han, Hwarang S., et al.
Publicado: (2023)

Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient
Publicado: (1982)

Protosappanin‐A and oleanolic acid protect injured podocytes from apoptosis through inhibition of AKT‐mTOR signaling
por: Zheng, Jiaxin, et al.
Publicado: (2019)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
por: Aby, Elizabeth, et al.
Publicado: (2017)

Systemic Immunosuppression for Limbal Allograft and Allogenic Limbal Epithelial Cell Transplantation
por: Serna-Ojeda, Juan Carlos, et al.
Publicado: (2020)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Renal allograft transplant recipient with ruptured hydatid native kidney
por: Bhat, Riyaz Ahmad, et al.
Publicado: (2014)

Disseminated Tuberculosis Involving Allograft in a Renal Transplant Recipient
por: Sutariya, Harsh C., et al.
Publicado: (2016)

Hyaluronan and LYVE-1 and allograft function in lung transplantation recipients
por: Courtwright, Andrew M., et al.
Publicado: (2019)

Endotrophin Levels Are Associated with Allograft Outcomes in Kidney Transplant Recipients
por: Sparding, Nadja, et al.
Publicado: (2023)

Simultaneous determination of brazilin and protosappanin B in Caesalpinia sappan by ionic-liquid dispersive liquid-phase microextraction method combined with HPLC
por: Xia, Zhaoyang, et al.
Publicado: (2017)

Validation of Prognostic Index for Allograft Outcome in Kidney Transplant Recipients With Transplant Glomerulopathy
por: Talwar, Manish, et al.
Publicado: (2020)

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
por: Johansson, Inger, et al.
Publicado: (2015)

Differentially Expressed Gene Transcripts Using RNA Sequencing from the Blood of Immunosuppressed Kidney Allograft Recipients
por: Dorr, Casey, et al.
Publicado: (2015)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges
por: Ebrahimi, Ammar, et al.
Publicado: (2014)

Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018)

Regional delivery of immunosuppression for transplantation of vascularized composite allografts: opportunities near and far
por: Platt, Jeffrey L., et al.
Publicado: (2021)

Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-κB signaling pathway in hyperlipidemic rabbits
por: Huang, Ying, et al.
Publicado: (2018)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
por: Anton Pampols, Paula, et al.
Publicado: (2021)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Allograft and prostatic involvement in a renal transplant recipient with disseminated tuberculosis
por: Sreejith, P., et al.
Publicado: (2010)

Predictive value of procalcitonin in chronic allograft dysfunction in kidney transplant recipients
por: Yao, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fdqa7727sdra0qt09dkudjuaqb